A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates ...

MD Anderson Cancer Center is one of the world's most respected centers devoted exclusively to cancer patient care, research, education, and prevention. MD Anderson has ranked among the nation's top ...

Follicular lymphoma is an indolent malignancy with a generally favorable prognosis, with survival often measured in decades. Yet up to 20% of patients develop early progression after starting ...

Researchers at MD Anderson Cancer Center at the University of Texas ... Results from an early-stage safety trial in B-cell lymphoma have not shown any incidence of cytokine release syndrome ...

Houston-based University of Texas MD Anderson Cancer Center broke ground on a new facility in Sugar Land, Texas, set to be the system’s largest location yet. Services at the new facility will ...

During a March Becker’s Hospital Review webinar sponsored by LeanTaaS, LeeAnn Mengel, RN, MBA, CMPE, FACHE, vice president and administrator of Baptist MD Anderson Cancer Center (Jacksonville ...

For more information, click here. From MD Anderson Cancer Center The University of Texas MD Anderson Cancer Center is one of the world's most respected centers devoted exclusively to cancer ...